Ignite SD
0
Login
Register
Viewing StudyNCT06351332
Home
Search
Stocks
Certify Doc
Genes
Clinical Trials
CompTox
DrugMatrix
Open Targets
Products
Support
Bugs
eRecord
Main Search
All Studies
All Organizations
Report Bug
View Study With Definitions
Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06351332
Status:
SUSPENDED
Last Update Posted:
2024-06-20
First Post:
2024-04-02
Brief Title:
ZAP-IT ZN-c3 Carboplatin Pembrolizumab in MTNBC
Sponsor:
Filipa Lynce MD
Organization:
Dana-Farber Cancer Institute
Overview
Dates
Organization
Conditions
Design
Enrollment
Locations
Outcomes
Conditions & Keywords Data
Conditions:
Name
Breast Cancer
Breast Cancer Female
Triple Negative Breast Cancer
Hormone Receptor Negative Malignant Tumor Breast Triple
HER2-negative Breast Cancer
Keywords:
Name
View
HER2-negative Breast Cancer
View
Breast Cancer
View
Breast Cancer Female
View
Triple Negative Breast Cancer
View
Hormone Receptor Negative Malignant Tumor Breast Triple
View